Dana Ferraris

6.1k citations

68 papers · 4.9k indexed · 1 hit paper · h-index 32

Co-authors: Thomas Lectka Takashi Tsukamoto Brandon Young Camilo Rojas William J. Drury Christopher D. Cox Travis Dudding Barbara S. Slusher
Topics: PARP inhibition in cancer therapy (14 papers)Amino Acid Enzymes and Metabolism (13 papers)Chemical Synthesis and Analysis (10 papers)
Cited by: Cancer Research Biochemistry Biological Psychiatry
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Journal of Neuroscience
Partner nations: United States Czechia Finland

In The Last Decade

Dana Ferraris

67 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type

2012 515 citations Mariia Yuneva, Teresa W.‐M. Fan et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Dana Ferraris

Since Specialization

Citations

This map shows the geographic impact of Dana Ferraris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Ferraris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Ferraris more than expected).

Fields of papers citing papers by Dana Ferraris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Ferraris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Ferraris. The network helps show where Dana Ferraris may publish in the future.

Co-authorship network of co-authors of Dana Ferraris

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Ferraris. A scholar is included among the top collaborators of Dana Ferraris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Ferraris. Dana Ferraris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of a series of pyrrolo-pyrimidine-based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication 2025 ·mBio ·(unknown),(unknown),(unknown),(unknown),Iain Colquhoun,(unknown),(unknown),(unknown),(unknown),Joseph O’Connor,(unknown),(unknown),(unknown),Michael J. Hageman,David K. Johnson,Anuradha Roy,L. Lehtiö,Dana Ferraris,Anthony R. Fehr	0
2	PARP14 Contributes to the Development of the Tumor-Associated Macrophage Phenotype 2024 ·International Journal of Molecular Sciences ·(unknown),(unknown),Zsolt Regdon,Anett Mázló,(unknown),Attila Bácsi,(unknown),Csaba Hegedűs,Mark Boothby,(unknown),Dana Ferraris,H. Schüler,László Virág	6
3	Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target 2024 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),(unknown),Sven T. Sowa,Albert Galera‐Prat,Dana Ferraris,Mirko M. Maksimainen,Anthony R. Fehr,Juha P. Heiskanen,L. Lehtiö	6
4	An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors 2023 ·Pathogens ·(unknown),Dana Ferraris,Anthony R. Fehr	4
5	Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors 2018 ·Bioorganic & Medicinal Chemistry ·Cyril Bařinka,Zora Nováková,Niyada Hin,Daniel Bím,Dana Ferraris,Bridget Duvall,(unknown),(unknown),Miloš Buděšı́nský,L. Motlova,Camilo Rojas,Barbara S. Slusher,Tibor András Rokob,Lubomı́r Rulı́šek,Takashi Tsukamoto	19
6	Design, synthesis and evaluation of potent and selective inhibitors of mono-(ADP-ribosyl)transferases PARP10 and PARP14 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),A.G. Thorsell,T. Karlberg,(unknown),Ryan E. Grant,(unknown),(unknown),H. Schüler,Dana Ferraris	30
7	D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog 2015 ·Neuropsychopharmacology ·Camilo Rojas,Jesse Alt,Nancy A. Ator,Ajit G. Thomas,Ying Wu,Niyada Hin,Krystyna M. Wozniak,Dana Ferraris,Rana Rais,Takashi Tsukamoto,Barbara S. Slusher	20
8	Synthesis of kojic acid derivatives as secondary binding site probes of d-amino acid oxidase 2013 ·Bioorganic & Medicinal Chemistry Letters ·Mithun Raje,Niyada Hin,Bridget Duvall,Dana Ferraris,James F. Berry,Ajit G. Thomas,Jesse Alt,Camilo Rojas,Barbara S. Slusher,Takashi Tsukamoto	20
9	The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Typebreakdown → 2012 ·Cell Metabolism ·Mariia Yuneva,Teresa W.‐M. Fan,Thaddeus D. Allen,Richard M. Higashi,Dana Ferraris,Takashi Tsukamoto,José M. Matés,Francisco J. Alonso,Chunmei Wang,Youngho Seo,Xin Chen,J. Michael Bishop	515
10	Reduced BACE1 Activity Enhances Clearance of Myelin Debris and Regeneration of Axons in the Injured Peripheral Nervous System 2011 ·Journal of Neuroscience ·Mohamed H. Farah,(unknown),Paul N. Hoffman,Dana Ferraris,Takashi Tsukamoto,Thien Huu Nguyen,Philip C. Wong,Donald L. Price,Barbara S. Slusher,John W. Griffin	69
11	Development of a high-throughput method for the determination of pharmacological levels of plasma d-serine 2011 ·Analytical Biochemistry ·Jesse Alt,Camilo Rojas,Krystyna M. Wozniak,Ying Wu,Dana Ferraris,Takashi Tsukamoto,Barbara S. Slusher	6
12	Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1 2010 ·Cancer Research ·Meghan J. Seltzer,Bryson D. Bennett,Avadhut D. Joshi,Ping Gao,Ajit G. Thomas,Dana Ferraris,Takashi Tsukamoto,Camilo Rojas,Barbara S. Slusher,Joshua D. Rabinowitz,Chi V. Dang,Gregory J. Riggins	410
13	Glutamate production by HIV‐1 infected human macrophage is blocked by the inhibition of glutaminase 2007 ·Journal of Neurochemistry ·Nathan Erdmann,Jianxing Zhao,Alicia López‐Castellano,Shelley Herek,Norman P. Curthoys,Terry D. Hexum,Takashi Tsukamoto,Dana Ferraris,Jialin Zheng	47
14	Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV) 2007 ·Current Topics in Medicinal Chemistry ·Dana Ferraris,Sergei A. Belyakov,Weixing Li,(unknown),(unknown),David C. Calvin,(unknown),Bert E. Thomas,Camilo Rojas	22
15	Accumulation of Free ADP-ribose from Mitochondria Mediates Oxidative Stress-induced Gating of TRPM2 Cation Channels 2004 ·Journal of Biological Chemistry ·Anne-Laure Perraud,Christina L. Takanishi,Betty Shen,Shin Jung Kang,Megan Smith,Carsten Schmitz,(unknown),Dana Ferraris,Weixing Li,Jie Zhang,Barry Stoddard,Andrew M. Scharenberg	290
16	Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Dana Ferraris,(unknown),David C. Calvin,(unknown),(unknown),Bert E. Thomas,Krystyna M. Wozniak,Camilo Rojas,Vincent J. Kalish,Sergei A. Belyakov	19
17	Design and synthesis of poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Part 3: In vitro evaluation of 1,3,4,5-Tetrahydro-benzo[c][1,6]- and [c][1,7]-naphthyridin-6-ones 2003 ·Bioorganic & Medicinal Chemistry Letters ·Dana Ferraris,(unknown),Thomas F. Pahutski,(unknown),Shirley Huang,Jie Zhang,Vincent J. Kalish	28
18	Synthesis of substituted 5[H]phenanthridin-6-ones as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jia-He Li,(unknown),Dana Ferraris,Ge� Xiao,(unknown),(unknown),Weixing Li,(unknown),Jie Zhang,Vincent J. Kalish	49
19	Catalytic, enantioselective alkylations of N,O- and N, N-acetals and hemiacetals 1999 ·Tetrahedron ·Dana Ferraris,Brandon Young,Travis Dudding,William J. Drury,Thomas Lectka	30
20	Statistical distribution of hydrogen over three positions in the brucite Mg(OH) 2 structure from electron diffractometry data 1997 ·(unknown),А. С. Авилов,Dana Ferraris,B. B. Zvyagin,(unknown)	9

About Dana Ferraris

Dana Ferraris is a scholar working on Biochemistry, Physiology and Biological Psychiatry, having authored 68 papers that have together received 4.9k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (14 papers), Amino Acid Enzymes and Metabolism (13 papers) and Chemical Synthesis and Analysis (10 papers). The work is most often cited by research in Cancer Research (1.2k citations), Biochemistry (540 citations) and Biological Psychiatry (171 citations). Dana Ferraris has collaborated with scholars based in United States, Czechia and Finland. Frequent co-authors include Thomas Lectka, Takashi Tsukamoto, Brandon Young, Camilo Rojas, William J. Drury, Christopher D. Cox, Travis Dudding, Barbara S. Slusher, Andrew E. Taggi and Ajit G. Thomas. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact